Centessa Pharmaceuticals PLC ADR (CNTA) support and resistance · $6.15B cap
Centessa Pharmaceuticals PLC ADR (CNTA) is a biotechnology company listed on US.
This page maps Centessa Pharmaceuticals PLC ADR (CNTA) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported CNTA revenue for 2024-12-31 was $0. Net income was -$235.8M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. CNTA currently screens at market cap $6.15B.
CNTA currently screens at market cap $6.15B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new CNTA 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the CNTA quote page for the session range and the stock page for the full model.
Not investment advice.